Te Whatu Ora sees end of GP2GP Te Whatu Ora Health New Zealand has revealed actions to address the immediate risks of the “outdated” GP2GP electronic patient record transfer system.
The system, which was introduced in…
Top News
UnitedHealth Group announces that CEO Andrew Witty has resigned for personal reasons and has been replaced by Chairman and former CEO Stephen Hemsley.
The company also announced that it will suspend its 2025…
Integrating large language models (LLMs) into healthcare can enhance workflow efficiency and patient care by automating tasks such as summarising consultations. However, the fidelity between LLM outputs and ground truth information is vital to…
Continue Reading
Olio, a platform that links hospital teams with post-acute providers for care collaboration, scored $11 million in Series B funding led by Fulcrum Equity Partners.Mutual Capital Partners also participated in the round.
WHAT IT DOES
Olio’s…
The global AI healthcare market, valued at USD 29.01 billion in 2024, is projected to reach USD 504.17 billion by 2032. In Europe alone, the market is expected to grow from USD 7.92 billion…
Continue Reading
Oregon Health & Science University Hospital is a 576-bed teaching hospital, biomedical research facility and Level I trauma center located on the campus of Oregon Health & Science University in Portland. It is at…
Continue Reading
Andrew Witty, Former CEO at UnitedHealth Group
What You Should Know:
– UnitedHealth Group today announced a significant leadership transition, with Stephen J. Hemsley being re-appointed as its chief executive officer, effective immediately.
– Hemsley, who previously…
Continue Reading
What You Should Know:
– Celery, a financial operations platform leveraging artificial intelligence to automate internal controls secures $6.25M in seed funding led by Team8 Capital, with participation from Verissimo Ventures, Centre Street Partners, 97212…
Continue Reading
Russell Senger, Vice President of Community Development at The Beryl Institute, describes in this video the multiplicity of services focused on "improving the patient experience" and how they play out at the Institute's conference.Some…
Continue Reading
Patent Monopolies Drive Record Profits
Novo Nordisk and Eli Lilly have transformed GLP-1 receptor agonists into unprecedented profit machines. These blockbuster drugs, approved for diabetes and weight loss, generate billions while leaving many patients unable…
